<html><body><pre>[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 139 Referred in House (RFH)]

114th CONGRESS
  1st Session
                                 S. 139


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 20, 2015

  Referred to the Committee on Ways and Means, and in addition to the 
   Committee on Energy and Commerce, for a period to be subsequently 
   determined by the Speaker, in each case for consideration of such 
 provisions as fall within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 AN ACT


 
   To permanently allow an exclusion under the Supplemental Security 
 Income program and the Medicaid program for compensation provided to 
  individuals who participate in clinical trials for rare diseases or 
                              conditions.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ensuring Access to Clinical Trials 
Act of 2015''.

SEC. 2. ELIMINATION OF SUNSET PROVISION.

    Effective as if included in the enactment of the Improving Access 
to Clinical Trials Act of 2009 (Public Law 111-255, 124 Stat. 2640), 
section 3 of that Act is amended by striking subsection (e).

            Passed the Senate July 16, 2015.

            Attest:

                                                JULIE E. ADAMS,

                                                             Secretary.
</pre></body></html>
